All News

diet.better.jpg

NY Times on Arthritis Prevention

d Jack Cush, MD

A reader question ("Ask Well") to the New York times wonders "is arthritis avoidable"?



A recent survey suggests that up to 60% of adults have been told by an HCP they had some form of arthritis.

Read Article
RheumNow Podcast square

Want to Go Far, Go Together (4.21.2023)

d Jack Cush, MD

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Read Article
GCA temporal artery

Aging Mechanisms Tied to Giant Cell Arteritis

d MedPage Today

Senescence pathways are involved in giant cell arteritis (GCA), an analysis of patient tissue samples suggested, which may account for the efficacy of one agent now used for the disease and another in commercial development.

Read Article
diversity together global leadership

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun

d Jinoos Yazdany, MD, MPH

Collaboration has proven to be an essential ingredient for progress and innovation in rheumatology. Effective collaboration requires generosity with your time and resources. Here are some things that I’ve learned over the years about successful collaborations in rheumatology.

Read Article
Immune Checkpoint Inhibitor Safety with Pre-existing Rheumatoid Arthritis Lancet Rheumatology has published a retrospective analysis showing patients receiving ICI for cancer have the same outcomes even when they have pre-existing RA. https://t.co/aFNZX5YaLD https://t.co/ZY9Ie8TOPc

Links:

Dr. John Cush RheumNow ( View Tweet)
Brigham review (2018-2022) of 47 CPPD pts: M=F, mean age 72 yrs 68% w/ acute CPP arthritis 40% w/ CPP inflammatory arthritis 62% w/ OA with CPPD. Compared to Gout, CPPD Significant unmet Rx need & lower RAPID3 (8.1 vs 12.1) https://t.co/cLNjGxi6qF https://t.co/76PoepxRjR

Links:

Dr. John Cush RheumNow ( View Tweet)
The European Commission has approved upadacitinib (Rinvoq) for the Treatment of Moderately to Severely Active Crohn's Disease https://t.co/Ltun2fdRn9 https://t.co/033PCqIlrv

Links:

Dr. John Cush RheumNow ( View Tweet)
Retrospective study of 147 THA and TKA pts w/ acute/chronic complaint - 39 pts Dx w/ prosthetic joint infection (PJI). Absolute numbers of neutrophils (PMNs) best predicted PJI (THA > 3,600 PMN/µl; TKA >2,000 PMN/µl (sensitivity 97%; specificity 93.5%) https://t.co/hZ8rpgJUZu https://t.co/CiSEvg9xPQ

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Alexis Ogdie discusses sex differences in patients with psoriatic arthritis. Learn more. https://t.co/JTSHAKBfhN https://t.co/f0rfDQAY6T

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us 4/25 as we conclude our Women in Rheumatology campaign by focusing on what's next. Our panelists will recap the challenges addressed this month and discuss a strategy to suppot women in rheumatology. https://t.co/DP4S2hf5Tz @uptoTate @KDAO2011 @gwenesta_melton https://t.co/rcglaZxqoF

Links:

Dr. John Cush RheumNow ( View Tweet)
New download available! Private Practice vs Academic Medicine https://t.co/APzQGpcwm6 https://t.co/qAtyPFGquV

Links:

Dr. John Cush RheumNow ( View Tweet)
Sex-Specific Differences in Psoriatic Arthritis A systematic review of published literature on PsA, clinical features, disease activity, and PROs shows generally higher levels of disease activity in women, compared to men with PsA. https://t.co/dMvLSwzWIt https://t.co/Cz8aIID3HX

Links:

Dr. John Cush RheumNow ( View Tweet)
TNR: Private Practice & Academia In this session, our panelists addressed the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?". https://t.co/yMJ5mCtSXX @KDAO2011 https://t.co/eeFYkLYsAh

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Philip Mease speaks about the effect of sex and gender on rheumatology disease activity and treatment response. Learn more. https://t.co/vKZfFLFmgs https://t.co/kRA0w9hRX7

Links:

Dr. John Cush RheumNow ( View Tweet)
CIRCS study: Comparison of 3188 Gout (733 M: 355 F) and ~10K non-gout. Found that the risk of gout in men linked to HTN (HR 1.41)and alcohol (HR 1.23 & 1.41), but that only smoking was a risk factor among women (HR 1.66). https://t.co/ODQW3SUjet https://t.co/Y8FTpbeXd5

Links:

Dr. John Cush RheumNow ( View Tweet)
NIH sponsored nationwide survey assessed 1,462 SLE pts (9% men; 81% women). Male SLE pts had more MI & difficultly w/ medical forms than F. Female SLE had more fatiguer and higher educational levels. Both had barriers to health care access (40-47%) https://t.co/A0Zv5IvXnh https://t.co/BFMspCs6yE

Links:

Dr. John Cush RheumNow ( View Tweet)
CDC defines Health equity as a state where everyone has a fair & just opportunity to attain their highest level of health; requires efforts to: address injustices; overcome economic;social obstacles to health & eliminate preventable health disparities https://t.co/fYviqSBIse https://t.co/XuRZ4xJdXH

Links:

Dr. John Cush RheumNow ( View Tweet)
Renal Function Safe With Pegloticase-MTX Combo for Gout For patients with uncontrolled gout, estimated glomerular filtration rate (eGFR) remained stable with combination pegloticase (Krystexxa) and methotrexate treatment, researchers reported. https://t.co/cInxAUrQiR https://t.co/MoBKUMKfjP

Links:

Dr. John Cush RheumNow ( View Tweet)
Women Rheumatologists Leading in the Private Sector There are many opportunities outside of academic medicine to flex your leadership muscle. https://t.co/Ifusp8Crvf https://t.co/JMDjhzffOP

Links:

Dr. John Cush RheumNow ( View Tweet)
JAMA Dermatology Patient Education page - Sarcoidosis of the Skin https://t.co/aPbTjl3pXv https://t.co/wCbjlUeFkj

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×